Jonae Barnes | executive |
Jean-Pierre Sommadossi | executive |
Maria Horga | executive |
Janet Hammond | executive |
John Vavricka | executive |
Andrea Corcoran | executive |
Maxwell Skor | analyst |
Jonathan Miller | analyst |
Good afternoon, everyone, and welcome to the Atea Pharmaceuticals Second Quarter 2024 Financial Results and Business Update Conference Call. [Operator Instructions] Following the formal remarks, we will open the call up for your questions. I would now like to turn the call over to Jonae Barnes, Senior Vice President of Investor Relations and Corporate Communications at Atea Pharmaceuticals. Ms. Barnes, please proceed.
Thank you.